Pure Hydrogen for Pharmaceutical Manufacturing

Hydrogenation in Pharmaceutical Synthesis

Catalytic hydrogenation is one of the most commonly used reactions in pharmaceutical chemistry. It is employed to reduce functional groups, saturate double bonds, remove protecting groups, and perform reductive aminations in the synthesis of active pharmaceutical ingredients (APIs). These reactions typically use precious metal catalysts such as palladium on carbon (Pd/C) or platinum oxide, which are highly sensitive to hydrogen purity.

Impurities in the hydrogen stream, particularly carbon monoxide, sulfur compounds, and trace hydrocarbons, can poison these expensive catalysts, reducing yields and requiring premature catalyst replacement. Electrolytic hydrogen from water splitting is inherently free of these contaminants, making it the ideal H2 source for pharmaceutical hydrogenation.